Chemotherapy
Cancer therapy may impair cardiorespiratory fitness for years after treatment
Cancer treatment, primarily chemotherapy, is associated with impaired cardiorespiratory fitness years after treatment has ended and regardless of cancer subtype, according to a meta-analysis published in JACC: CardioOncology.
High prevalence of atherosclerosis detected in patients entering lung cancer therapy
CT imaging of patients entering lung cancer treatment identified a high prevalence of atherosclerosis, according to data presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient course.
Regimen may become new standard for relapsed/refractory diffuse large B-cell lymphoma
The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with relapsed or refractory diffuse large B-cell lymphoma, according to results of a phase 1b/phase 2 trial.
Study links beta blocker use to mortality after stem cell transplantation
Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression of signals from nerves that promote bone marrow regeneration, according to study results.
Cardiovascular disease after breast cancer linked to poorer oncologic outcomes
Breast cancer survivors who developed incident myocardial infarction or heart failure exhibited increased risk for adverse oncologic outcomes, according to a population-based cohort study.
Program improves surgical outcomes, preserves independence for older adults with cancer
An American College of Surgeons initiative reduced postoperative hospitalization among older adults with cancer, according to study findings.
VIDEO: Brain cancer recovery phase necessary to prepare for possible regrowth
In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses monitoring patients following their initial treatment.
Chemotherapy shortages did not increase short-term mortality for people with advanced cancer
The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term mortality rates among people with advanced cancer, according to results of a cohort study.
Immune checkpoint inhibitors with transplant improve survival in relapsed Hodgkin lymphoma
Pre-transplant immune checkpoint inhibitors extended survival for patients with relapsed classic Hodgkin lymphoma compared with chemotherapy, according to results of a retrospective study.
Q&A: Lower blood thinner dose can reduce bleeding risk
Reduced dosing of direct oral anticoagulants may offer comparable efficacy as full dosing for adults with venous thromboembolism history while decreasing bleeding risk and reducing health care utilization, according to study results.